Internal Medicine, Pulmonary Disease · Pagosa Springs, CO
NPI
1134107006
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
95 S Pagosa Blvd
Pagosa Springs, CO, 81147
Phone (970) 731-3700
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
1,416 services
Medicare patients, 2024
658
Average age 75
Drug cost, 2024
$2.8M
3,547 prescriptions
Company payments, 2024
$71.94
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barry W Holcomb Jr. was code 99214 (office e&m - established), 375 times for 291 patients. In total Barry W Holcomb Jr. billed 1,416 services in 20 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 375 | 291 | $88.99 | $33K |
| 99215 Office E&M - Established | Office | 281 | 190 | $140.41 | $39K |
| 94729 Pulmonary Function Testing | Facility | 206 | 203 | $6.42 | $1,323 |
| 94726 Pulmonary Function Testing | Facility | 198 | 195 | $8.63 | $1,709 |
| 94060 Pulmonary Function Testing | Facility | 125 | 125 | $7.59 | $949 |
| 99205 Office E&M - New | Office | 93 | 93 | $175.44 | $16K |
| 94010 Pulmonary Function Testing | Facility | 91 | 88 | $5.72 | $520 |
By year: 2022 $145K for 2,698 services; 2023 $114K for 2,187 services; 2024 $97K for 1,416 services.
Medicare prescription drug claims, 2024
In 2024, the drug Barry W Holcomb Jr. prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 636 prescriptions and refills. In total Barry W Holcomb Jr. wrote 3,547 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 636 | 917 | 131 | $571K |
| Montelukast Sodium Generic | 522 | 1,011 | 122 | $5,253 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 249 | 341 | 83 | $11K |
| Symbicort Budesonide/Formoterol Fumarate | 228 | 410 | 72 | $91K |
| Prednisone Generic | 188 | 227 | 90 | $815 |
| Pantoprazole Sodium Generic | 173 | 268 | 34 | $1,865 |
| Advair Hfa Fluticasone Propion/Salmeterol | 136 | 213 | 41 | $80K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 126 | 181 | 31 | $23K |
| Spiriva Respimat Tiotropium Bromide | 84 | 121 | 15 | $56K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 68 | 95 | 28 | $15K |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 66 | 81 | 12 | $43K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 53 | 55 | 11 | $24K |
| Azithromycin Generic | 46 | 52 | 34 | $250 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 43 | 49 | 13 | $28K |
| Ventolin Hfa Albuterol Sulfate | 42 | 49 | 20 | $2,770 |
Brand drugs: 2,077 claims; generic drugs: 1,470 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Barry W Holcomb Jr. $71.94 ($71.94 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $50.37.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50.37 |
| Genzyme Corporation SNY | 1 | $21.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.